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Abstract
Background: Systematic reviews and meta-analyses of test accuracy studies are increasingly being
recognised as central in guiding clinical practice. However, there is currently no dedicated and
comprehensive software for meta-analysis of diagnostic data. In this article, we present Meta-DiSc,
a Windows-based, user-friendly, freely available (for academic use) software that we have
developed, piloted, and validated to perform diagnostic meta-analysis.
Results: Meta-DiSc a) allows exploration of heterogeneity, with a variety of statistics including chi-
square, I-squared and Spearman correlation tests, b) implements meta-regression techniques to
explore the relationships between study characteristics and accuracy estimates, c) performs
statistical pooling of sensitivities, specificities, likelihood ratios and diagnostic odds ratios using fixed
and random effects models, both overall and in subgroups and d) produces high quality figures,
including forest plots and summary receiver operating characteristic curves that can be exported
for use in manuscripts for publication. All computational algorithms have been validated through
comparison with different statistical tools and published meta-analyses. Meta-DiSc has a Graphical
User Interface with roll-down menus, dialog boxes, and online help facilities.
Conclusion: Meta-DiSc is a comprehensive and dedicated test accuracy meta-analysis software. It
has already been used and cited in several meta-analyses published in high-ranking journals. The
software is publicly available at http://www.hrc.es/investigacion/metadisc_en.htm.
Background
Accurate diagnosis forms the basis of good clinical care, as
without it one can neither prognosticate correctly nor
choose the right treatment. Indeed, a wrong diagnosis can
harm patients by exposing them to inappropriate or sub-
optimal therapy [1]. Thus studies of diagnostic accuracy,
and particularly their systematic reviews and meta-analy-
ses, are being recognised as instrumental in underpinning
evidence-based clinical practice. Initiatives such as STARD
[2] and developments within the Cochrane Collaboration
[3] to accept protocols and reviews of test accuracy studies
highlight the emphasis being given to evidence-based
diagnosis.
Currently, there is only one test accuracy meta-analysis
package, Meta-Test [4], which addresses some of the
unique statistical issues related to test accuracy, such as
pooling of sensitivities and specificities and summary
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receiver operating characteristics (sROC) analysis. How-
ever, it is a DOS-based application with an interface that
many find difficult to use, and integrate into Windows-
based applications. Moreover, it lacks crucial analytical
tools such as pooling of likelihood ratios (LRs), tests for
heterogeneity and meta-regression facilities.
We, therefore, developed, piloted and validated a compre-
hensive, Windows-based test accuracy meta-analysis soft-
ware, Meta-DiSc, which is presented in this article, with a
worked example.
Implementation
Meta-DiSc software was created in Microsoft Visual Basic
6, and some mathematical routines have been linked
from the NAG C mathematical library [5]. The software is
distributed as a single file, downloadable freely from URL:
http://www.hrc.es/investigacion/metadisc_en.htm. Its
installation is simple, guided by onscreen instructions.
The programme has a user-friendly interface with roll-
down menus, dialog boxes and online HTML compiled
help files. These help files include a user manual and a
description of the implemented statistical methods.
Meta-DiSc allows data entry into its datasheet in three dif-
ferent ways: a) directly by typing data into the datasheet
using the keyboard, b) copying from another spreadsheet
(e.g. Microsoft Excel) and pasting into Meta-DiSc datash-
eet, or c) importing text files from other sources (for exam-
ple, in the comma delimited format). Several variables
can be defined in the datasheet, including study identifi-
ers, accuracy data from each study (true positives, false
positives, true negatives and false negatives) and study
level co-variates, such as those defining population spec-
trum or methodological quality of the studies.
Once the data have been entered into the datasheet of
Meta-DiSc, various statistical analyses can be imple-
mented (Figure 1). The implementation of these statistical
procedures needs to be carefully thought through and
judicious, as it may be inappropriate (or indeed mislead-
ing) to use all the procedures (particularly statistical pool-
ing) in all reviews. Meta-DiSc provides analysts with
adequate tools to assess the appropriateness of pooling.
Readers interested in details of these methods are referred
to statistical methods section of the help files (also avail-
able as a PDF standalone document [6] and to existing
texts and guidelines on diagnostic meta-analysis [7-10].
Describing the results of individual studies
When describing accuracy results from several studies, it is
important to get an indication of the magnitude and pre-
cision of the accuracy estimates derived from each study,
as well as to assess the presence or absence of inconsisten-
cies in accuracy estimates across studies (heterogeneity).
As accuracy estimates are paired and often inter-related
(sensitivity and specificity, or LR positive and LR nega-
tive), it is necessary to report these simultaneously [11].
One accuracy measure that combines these paired meas-
ures is diagnostic odd ratio (dOR) [12], which has limited
clinical use, although useful in procedures like meta-
regression (see below).
Meta-DiSc computes accuracy estimates and confidence
intervals from individual studies and shows results either
as numerical tabulations or graphical plots in two for-
mats: a) forest plots, for sensitivities, specificities, LRs or
dOR, with respective confidence intervals; and b) plots of
individual study results in ROC space, with or without an
sROC curve.
Exploring heterogeneity (threshold effect)
Exploring heterogeneity is a critical issue to a) understand
the possible factors that influence accuracy estimates, and
b) to evaluate the appropriateness of statistical pooling of
accuracy estimates from various studies. One of the pri-
mary causes of heterogeneity in test accuracy studies is
threshold effect, which arises when differences in sensitiv-
ities and specificities or LRs occur due to different cut-offs
or thresholds used in different studies to define a positive
(or negative) test result. When threshold effect exists,
there is a negative  correlation between sensitivities and
specificities (or a positive correlation between sensitivities
and 1-specificities), which results in a typical pattern of
"shoulder arm" plot in a sROC space [8]. It is worth not-
ing that correlation between sensitivity and specificity
could arise due to a number of reasons other than thresh-
old (e.g. partial verification bias, different spectrum of
patients or different settings).
Available tools in Meta-DiSc Figure 1
Available tools in Meta-DiSc. Tools implemented in the 
software Meta-DiSc to perform different steps of meta-analy-
sis of diagnostic tests accuracy.
Describing primary results and exploring heterogeneity: 
• Tabular results. 
• Forest plots (sensitivity, specificity, LRs, dOR). 
• ROC plane scatter-plots. 
• Cochran-Q, Chi-Square, Inconsistency index. 
• Filtering/subgrouping capacities. 
Exploring Threshold effect: 
• Spearman correlation coefficient 
• ROC plane plots 
sROC curve fitting. Area under the curve (AUC) and Q*. 
Meta-regression analysis: 
• Univariate and multivariate Moses & Littenberg model 
(weighted or unweighted). 
Statistical pooling of indices: 
• Fixed effect model. 
• Random effect model. BMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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Meta-DiSc allows assessment for threshold effect in three
different ways: a) visual inspection of relationship
between pairs of accuracy estimates in forest plots. If
threshold effect is present, the forest plots will show
increasing sensitivities with decreasing specificities, or
vice versa. The same inverse relationship will be apparent
with LR positive and LR negative; b) representation of
accuracy estimates from each study in a sROC space – a
typical "shoulder arm" pattern would suggest presence of
threshold effect; and c) computation of Spearman correla-
tion coefficient between the logit of sensitivity and logit of
1-specificity. A strong positive correlation would suggest
threshold effect.
Exploring for heterogeneity (other than threshold effect)
Apart from variations due to threshold effect, there are
several other factors that can result in variations in accu-
racy estimates amongst different test accuracy studies in a
review. These reasons include chance as well as variations
in study population (e.g. severity of disease and co-mor-
bidities), index test (differences in technology, assays,
operator etc.), reference standard, and the way a study was
designed and conducted [13]. Since such heterogeneity is
almost always present in accuracy systematic reviews, test-
ing for the presence and the extent of heterogeneity of
results between primary studies, prior to undertaking any
meta-analysis, is a critical part of any diagnostic review, as
is exploration of the possible causes of heterogeneity [14].
Meta-DiSc allows users to test for heterogeneity amongst
various studies in two different ways: a) Visual inspection
of forest plots of accuracy estimates. If the studies are rea-
sonably homogeneous, the accuracy estimates from indi-
vidual studies will lie along a line corresponding to the
pooled accuracy estimate. Large deviations from this line
will indicate possible heterogeneity; b) statistical tests,
including Chi-square and Cochran-Q, which are automat-
ically implemented during analysis to evaluate if the dif-
ferences across the studies are greater than expected by
chance alone. A low p-value will suggest presence of het-
erogeneity beyond what could be expected by chance
alone. In addition to these heterogeneity statistics, Meta-
DiSc computes the inconsistency index (I-squared) which
has been proposed as a measure to quantify the amount
of heterogeneity [15].
Meta-regression
If substantial heterogeneity is found to be present from
the analyses detailed above, then reasons for such hetero-
geneity can be explored by relating study level co-variates
(e.g., population, test, reference standard or methodolog-
ical features) to an accuracy measure, using meta-regres-
sion techniques. The accuracy measure that is normally
used is dOR, as it is a unitary measure of diagnostic per-
formance that encompasses both sensitivity and specifi-
city or both LR positive and LR negative. Using dOR as a
global measure of accuracy is a suitable method to com-
pare the overall diagnostic accuracy of different tests [13].
However, its use is limited because it cannot be used
directly in clinical practice and, furthermore, possible
opposing effects of a study characteristic on sensitivity or
specificity may be masked by using dOR.
Meta-DiSc implements meta-regression using a generali-
zation of Littenberg and Moses Linear model [8,13]
weighted by inverse of the variance or study size or
unweighted. Random effects between studies can be esti-
mated by different methods and added to the weighting
scheme [16]. Estimations of coefficients of the model are
performed by least squares method as implemented in
NAG mathematical routines. The outcome variable is
ln(dOR) which is related via a linear model to any
number of study level covariates, and optionally includ-
ing the variable representing threshold effect [13]. The
outputs from meta-regression modelling in Meta-DiSc are
the co-efficients of the model, as well as ratio of dOR
(rdOR) with respective confidence intervals. If a particular
study level co-variate is significantly associated with diag-
nostic accuracy, then its co-efficient will have a low p-
value, and the rdOR will give a measure of magnitude of
the association.
More advanced meta-regression techniques such as Hier-
archical sROC model [17] and bivariate analysis of sensi-
tivity and specificity [18] has been developed. These
methods overcome some of the statistical shortcomings
inherent to Littenberg and Moses model [8,19].
Statistical pooling
Statistical pooling is not always appropriate or necessary
in every systematic review of test accuracy studies. How-
ever, when used appropriately, pooling can provide useful
summary information. The necessary precondition for
simple pooling (weighted averaging) of each of sensitivi-
ties, specificities, LR positives and LR negatives, is that the
studies and results are reasonably homogeneous (i.e. no
substantial heterogeneity, including threshold effect, is
present). If heterogeneity due to threshold effect were
present, the accuracy data can be pooled by fitting a sROC
curve and summarising that curve by means of the Area
Under the Curve (AUC) or using other statistics such as
the Q* index [19] (i.e. the point of the curve in which sen-
sitivity equals specificity). If there is heterogeneity due to
sources other than threshold effect, then pooling should
only be attempted within homogeneous subsets, which
would normally have been defined a priori.
Meta-DiSc has comprehensive functionality for statistical
pooling: a) It allows pooling of sensitivities, specificities,
LR positive and LR negative each separately, using eitherBMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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fixed or random effect [10,20] models. The output from
these analyses are presented numerically in tables, and
graphically as forest plots. Pooled estimates are provided
with their respective confidence intervals; b) It imple-
ments several ways to fit a sROC curve when threshold
effect is present. Default option is to compute a symmet-
rical sROC curve after fitting the linear model proposed by
Littenberg and Moses. However, users can choose differ-
ent options to fit this curve, for example, combining indi-
vidual dORs by the Mantel-Haenszel or the DerSimonian
Laird methods [10,20] to estimate an overall dOR, and
then fitting an sROC curve. When the dOR changes with
diagnostic threshold, the sROC curve is asymmetrical.
Meta-DiSc allows the user to check for asymmetry of the
sROC curve, and fit an asymmetrical sROC curve if appro-
priate. Finally, Meta-DiSc allows estimation of AUC and
the Q* index, along with their standard errors, as a sum-
mary measure of global accuracy which also aids inter-test
comparisons; c) Meta-DiSc allows pooling of various
summary measures within subgroups defined by study
level co-variates with the help of a filter utility.
Wherever possible, the results of the above statistical pro-
cedures were validated using different general purpose sta-
tistical software such as STATA (ver 8.2) and SAS (8.2)
using actually published and simulated data sets (Table
1).
Results
We illustrate the various procedures that Meta-DiSc
implements in a case-study of ultrasound test in the diag-
nosis of uterine pathology [21,22]. Ultrasound measure-
ment of the lining of the uterus (endometrium) can
predict pathology such as endometrial hyperplasia (a pre-
cancerous condition) or cancer. The greater the thickness
of endometrium, the more likely that the target condition
is present. Various thresholds (such as 3, 4 or 5 mm etc)
have been used to define a positive ultrasound result.
A systematic review of test accuracy studies identified 57
studies. Figure 2 shows a datasheet in Meta-DiSc which
has been loaded with information from these 57 studies.
The information includes study identifiers, accuracy data,
Table 1: Validation of statistical procedures. Validation of different statistical procedures using a simulated data-set. Results of Meta-
DiSc (version 1.4) are compared with those obtained with metan (version 1.86) and metareg (version 1.06) STATA commands. Prior 
to the analyses, all four cells of all studies were added with 1/2 to avoid division by zero when computing some indices or standard 
errors. Meta-DiSc and STATA data-set are provided as additional files [see Additional file 1] and [see Additional file 2].
Results
Procedure Meta-DiSc (version 1.4) STATA (ver 8.2)
Random Effect Model
Pooled +ve LR 2.447 2.447
(95%(CI) (2.085 – 2.871) (2.085 – 2.871)
Tau-square 0.0932 0.0932
Cochrane-Q 139.71 139.71
Pooled -ve LR 0.157 0.157
(95%(CI) (0.095 – 0.257) (0.095 – 0.257)
Tau-square 0.4631 0.46357
Cochrane-Q 33.00 33.07
Fixed Effect Model
Pooled +ve LR 2.330 2.330
(95%(CI) (2.208 – 2.459) (2.208 – 2.459)
Cochrane-Q 139.71 139.71
Pooled -ve LR 0.105 0.104
(95%(CI) (0.073 – 0.149) (0.073 – 0.148)
Cochrane-Q 33.00 33.07
Meta-Regression1
Tau-Square 0.1141 0.1141
Constant coefficient (SE) 2.520 (0.8370) 2.5197 (0.83699)
S coefficient (SE) 0.330 (0.1912) 0.3304 (0.19123)
Covariable coefficient (SE) -0.036 (0.0904) -0.0355 (0.09041)
(1) Meta-regression was weighted by the inverse of the variance of dOR and between study variance was estimated by REML.BMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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thresholds, and some study level co-variates (such as hor-
mone replacement therapy use).
As the first step in the analysis, we have used Meta-DiSc to
present accuracy measures from each individual study in
forest plots for sensitivities (figure 3a), specificities (figure
3b), LRs (figures 4a and 4b) and dOR (figure 5). All these
indices can also be represented in tabular form as shown
in table 2. Although the forest plots and the tables contain
a pooled summary at the bottom, at this early stage in the
analysis, it is recommended that the plots are used to
obtain a general overview of the accuracy estimates from
each study, and the interpretation of the pooled summary
is left to later stages of analysis.
The next step is the representation of sensitivity against 1-
specificity from each study in a ROC space (figure 6),
which can be used for exploration for threshold effect. The
pattern of the points in this plot suggest a "shoulder-arm"
shape, indicating the possibility of threshold effect. We,
therefore, performed a Spearman rank correlation as a fur-
ther test for threshold effect, and found that there was fur-
ther indication of threshold effect (Table 3, Spearman
correlation coefficient = 0.394; p = 0.006). Having found
some clues about the presence of threshold effect, we now
focus on a subgroup of 21 studies that used a singular
threshold of >5 mm to define test positivity. Although an
explicit threshold of 5 mm was used in these studies, there
can still be an implicit threshold effect due to, for exam-
ple, variation in the interpretation of the test results.
Therefore, within this subgroup with an explicit threshold
of 5 mm, it is still recommended that the above explora-
tions for threshold effect are undertaken. We performed
such analyses for this subgroup in Meta-DiSc, and found
no evidence of further threshold effect (data not shown).
There are a number of other more advanced methods not
Meta-Disc datasheet Figure 2
Meta-Disc datasheet. Meta-DiSc data set with details of test accuracy studies of ultrasound in the prediction of endometrial 
cancer.BMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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implemented in Meta-DiSc that allow to incorporate
explicitly information about tests thresholds defined
between or within studies [17].
As the next step, heterogeneity arising from factors other
than threshold effect is explored. We performed a visual
exploration of the forest plots of accuracy measures for
these 21 studies as well as statistical tests for heterogeneity
(Meta-DiSc output not shown). In addition, possible
sources of heterogeneity across the studies were explored
using meta-regression analysis with the following co-vari-
ates as predictor variables: use or non-use of hormone
replacement therapy (HRT); technique of ultrasound
measurement (single or double layer); and population
enrolment (consecutive or other). Results are shown in
Table 4, which suggest that the number of layers is
strongly associated with accuracy. The double layer tech-
nique is associated with two times higher accuracy com-
pared to single layer measurement (rdOR = 2.04; 95% CI:
1.01–4.13; p = 0.048)
The final step in the analysis is pooling if this is consid-
ered appropriate. We illustrate pooling of the LRs for neg-
ative test results in one homogenous subgroup of studies
of non-HRT users, with a test threshold of ≤ 5 mm, and
using a single layer technique (Figure 7). Finally, we dem-
onstrate sROC curve fitting in the presence of threshold
effect for the whole data-set in Figure 8.
Discussion and conclusion
Meta-DiSc allows description of individual study results;
exploration of heterogeneity with a variety of statistics
including chi-square, I-squared and Spearman correlation
tests; implements meta-regression techniques to explore
the relationships between study characteristics and accu-
racy estimates; performs statistical pooling of sensitivities,
Forest plot Figure 3
Forest plot. Forrest plot of sensitivities (3a) and specificities (3b) from test accuracy studies of ultrasound in the prediction of 
endometrial cancer.
A B
Specificity
0 0,2 0,4 0,6 0,8 1
Auslender 0,51    (0,42 - 0,61)
Zannoni 0,53    (0,49 - 0,57)
Bakour 0,49    (0,38 - 0,60)
Botsis 0,88    (0,80 - 0,93)
Fistonic 0,19    (0,12 - 0,29)
Garuti 0,33    (0,28 - 0,38)
Granberg 0,52    (0,49 - 0,55)
Guner 0,47    (0,39 - 0,55)
Haller 0,26    (0,16 - 0,39)
Tsuda 0,63    (0,55 - 0,71)
Varner 0,54    (0,25 - 0,81)
Abu Ghazzeh 0,38    (0,28 - 0,49)
Briley 0,51    (0,43 - 0,58)
Cacciatore 0,27    (0,14 - 0,43)
DeSilva 0,74    (0,60 - 0,86)
Granberg 0,76    (0,70 - 0,82)
Grigoriou 0,67    (0,60 - 0,73)
Gu 0,27    (0,11 - 0,50)
Gupta 0,64    (0,52 - 0,75)
Hänggi 0,79    (0,67 - 0,87)
Ivanov 0,58    (0,46 - 0,69)
Karlsson 0,65    (0,54 - 0,75)
Loverro 0,84    (0,74 - 0,91)
Malinova 0,49    (0,38 - 0,60)
Merz 0,43    (0,28 - 0,59)
Nasri 0,66    (0,52 - 0,78)
Nasri 0,61    (0,50 - 0,72)
Pertl 0,27    (0,19 - 0,35)
Suchocki 0,12    (0,06 - 0,20)
Taviani 0,54    (0,37 - 0,70)
Weber 0,39    (0,29 - 0,50)
Wolman 0,64    (0,49 - 0,77)
Moreles 0,61    (0,53 - 0,68)
Rudigoz 0,74    (0,59 - 0,86)
Todorova 0,50    (0,16 - 0,84)
Gruboeck 0,88    (0,80 - 0,94)
Chan 0,62    (0,47 - 0,75)
Degenhardt 0,66    (0,55 - 0,75)
Dijkhuizen 0,49    (0,36 - 0,62)
Brolmann 0,53    (0,39 - 0,66)
Ceccini 0,71    (0,66 - 0,76)
Masearetti 0,58    (0,33 - 0,80)
Mortakis 0,58    (0,45 - 0,69)
Schramm 0,50    (0,42 - 0,58)
Smith 0,54    (0,37 - 0,69)
Osmers 0,50    (0,43 - 0,57)
Seelbach-Göbel 0,44    (0,36 - 0,51)
Altuncu et al. 0,97    (0,85 - 1,00)
Specificity (95% CI)
Pooled Specificity = 0,54 (0,53 to 0,55)
Chi-square = 646,82; df =  47 (p = 0,0000)
Inconsistency (I-square) = 92,7 %
B
Sensitivity
0 0,2 0,4 0,6 0,8 1
Auslender 1,00    (0,79 - 1,00)
Zannoni 0,98    (0,90 - 1,00)
Bakour 1,00    (0,72 - 1,00)
Botsis 1,00    (0,63 - 1,00)
Fistonic 1,00    (0,77 - 1,00)
Garuti 0,98    (0,91 - 1,00)
Granberg 1,00    (0,97 - 1,00)
Guner 1,00    (0,82 - 1,00)
Haller 1,00    (0,79 - 1,00)
Tsuda 0,93    (0,68 - 1,00)
Varner 1,00    (0,16 - 1,00)
Abu Ghazzeh 1,00    (0,03 - 1,00)
Briley 1,00    (0,48 - 1,00)
Cacciatore 1,00    (0,40 - 1,00)
DeSilva 0,33    (0,01 - 0,91)
Granberg 1,00    (0,63 - 1,00)
Grigoriou 1,00    (0,86 - 1,00)
Gu 1,00    (0,59 - 1,00)
Gupta 0,67    (0,09 - 0,99)
Hänggi 0,86    (0,64 - 0,97)
Ivanov 1,00    (0,69 - 1,00)
Karlsson 0,93    (0,68 - 1,00)
Loverro 1,00    (0,86 - 1,00)
Malinova 1,00    (0,95 - 1,00)
Merz 1,00    (0,77 - 1,00)
Nasri 1,00    (0,59 - 1,00)
Nasri 1,00    (0,54 - 1,00)
Pertl 0,95    (0,74 - 1,00)
Suchocki 1,00    (0,88 - 1,00)
Taviani 1,00    (0,16 - 1,00)
Weber 0,98    (0,91 - 1,00)
Wolman 1,00    (0,40 - 1,00)
Moreles 0,91    (0,71 - 0,99)
Rudigoz 0,78    (0,40 - 0,97)
Todorova 1,00    (0,16 - 1,00)
Gruboeck 0,82    (0,48 - 0,98)
Chan 1,00    (0,80 - 1,00)
Degenhardt 0,86    (0,71 - 0,95)
Dijkhuizen 1,00    (0,63 - 1,00)
Brolmann 1,00    (0,69 - 1,00)
Ceccini 0,94    (0,70 - 1,00)
Masearetti 1,00    (0,29 - 1,00)
Mortakis 1,00    (0,59 - 1,00)
Schramm 0,62    (0,42 - 0,79)
Smith 1,00    (0,40 - 1,00)
Osmers 1,00    (0,87 - 1,00)
Seelbach-Göbel 0,95    (0,83 - 0,99)
Altuncu et al. 0,83    (0,36 - 1,00)
Sensitivity (95% CI)
Pooled Sensitivity = 0,96 (0,94 to 0,97)
Chi-square = 108,51; df =  47 (p = 0,0000)
Inconsistency (I-square) = 56,7 %BMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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specificities, likelihood ratios and diagnostic odds ratios,
using fixed and random effects models, both overall and
in subgroups; and produces high quality figures, includ-
ing forest plots and summary receiver operating character-
istic curves that can be exported for use in manuscripts for
publication.
Meta-DiSc is an evolving software. As new diagnostic
meta-analytic methods become established over time,
they will be implemented into the program in the future.
For example, bivariate method of pooling sensitivity and
specificity [18] is currently being developed. We will care-
fully follow the progress in this field. Once accepted as an
established meta-analytic method, it will be implemented
in Meta-DiSc. On similar lines, methods of data extraction
from individual studies that only provide accuracy meas-
ures are currently being developed within our depart-
ment. Once these methods have been verified, we will
implement this option to assist systematic reviewers in
extracting 2-by-2 tables from such studies.
Meta-DiSc is a comprehensive and dedicated test accuracy
meta-analysis software. All computational algorithms in it
have been validated through comparison with different
statistical tools and published meta-analyses. Its use and
citation in several meta-analyses published in high-rank-
ing journals is evidence of external validation of its high
quality [23-28].
Availability and requirements
The software is publicly available at http://www.hrc.es/
investigacion/metadisc_en.htm.
Operating system: The software runs on Windows based
personal computers (Windows 95 or higher) with Pen-
tium-class processor or equivalent, with minimum of 32
Forest plot Figure 4
Forest plot. Forrest plot of likelihood ratios for positive (4a) and negative (4b) test results from studies of ultrasound in the 
prediction of endometrial cancer.
A B
Positive LR
0,01 100,0 1
Auslender 1,99    (1,62 - 2,45)
Zannoni 2,09    (1,92 - 2,28)
Bakour 1,89    (1,49 - 2,41)
Botsis 7,36    (4,44 - 12,21)
Fistonic 1,20    (1,04 - 1,38)
Garuti 1,47    (1,36 - 1,59)
Granberg 2,07    (1,93 - 2,21)
Guner 1,83    (1,57 - 2,14)
Haller 1,32    (1,12 - 1,56)
Tsuda 2,52    (1,96 - 3,22)
Varner 1,79    (0,84 - 3,83)
Abu Ghazzeh 1,21    (0,54 - 2,75)
Briley 1,85    (1,40 - 2,47)
Cacciatore 1,24    (0,88 - 1,75)
DeSilva 1,31    (0,24 - 6,96)
Granberg 3,94    (2,93 - 5,28)
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Todorova 1,67    (0,73 - 3,81)
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Forrest plot Figure 5
Forrest plot. Forest plot of diagnostic odds ratios (dOR) from test accuracy studies of ultrasound in the prediction of 
endometrial cancer.
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Pooled Diagnostic Odds Ratio = 17,48 (11,59 to 26,37)
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Table 2: Tabulation of Likelihood ratio for positive test result (LR+) with respective 95% confidence intervals from all test accuracy 
studies included in systematic review of ultrasound for prediction of endometrial cancer.
Study LR+ [95% Conf. Iterval.] % Weight
Auslender 1,994 1,623 -2,449 2,54
Zannoni 2,092 1,919 -2,280 2,77
Bakour 1,895 1,490 -2,408 2,45
Botsis 7,360 4,437 -12,208 1,69
Fistonic 1,200 1,045 -1,378 2,69
Garuti 1,471 1,358 -1,593 2,78
Granberg 2,066 1,935 -2,206 2,79
Guner 1,834 1,569 -2,144 2,65
Haller 1,321 1,118 -1,561 2,63
Tsuda 2,517 1,964 -3,225 2,43
Varner 1,795 0,842 -3,826 1,13
Abu Ghazzeh 1,215 0,538 -2,745 1,03
Briley 1,855 1,396 -2,465 2,33
Cacciatore 1,239 0,877 -1,752 2,15
DeSilva 1,306 0,245 -6,957 0,34
Granberg 3,937 2,933 -5,284 2,30
Grigoriou 2,946 2,430 -3,572 2,57
Gu 1,307 0,956 -1,787 2,25
Gupta 1,846 0,783 -4,350 0,96
Hänggi 4,000 2,472 -6,473 1,76
Ivanov 2,273 1,691 -3,054 2,30
Karlsson 2,649 1,936 -3,627 2,24
Loverro 5,957 3,648 -9,729 1,73
Malinova 1,963 1,591 -2,421 2,53
Merz 1,697 1,287 -2,236 2,35
Nasri 2,740 1,833 -4,096 1,98
Nasri 2,400 1,711 -3,367 2,17
Pertl 1,293 1,115 -1,499 2,67
Suchocki 1,120 1,027 -1,222 2,77
Taviani 1,802 0,983 -3,304 1,44
Weber 1,618 1,374 -1,904 2,64
Wolman 2,481 1,556 -3,956 1,80
Moreles 2,312 1,845 -2,896 2,49
Rudigoz 2,981 1,638 -5,426 1,46
Todorova 1,667 0,729 -3,808 1,01
Gruboeck 7,036 3,689 -13,422 1,35
Chan 2,543 1,779 -3,635 2,12
Degenhardt 2,516 1,856 -3,411 2,27
Dijkhuizen 1,859 1,389 -2,489 2,31
Brolmann 2,017 1,487 -2,736 2,27
Ceccini 3,267 2,655 -4,021 2,54
Masearetti 2,059 1,096 -3,866 1,38
Mortakis 2,213 1,602 -3,058 2,22
Schramm 1,241 0,899 -1,714 2,22
Smith 1,938 1,252 -3,001 1,88
Osmers 1,964 1,699 -2,271 2,68
Seelbach-Göbel 1,680 1,455 -1,940 2,68
Altuncu et al. 29,167 4,089 -208,02 0,25
(REM) pooled LR+ 2,087 1,881 -2,315
Heterogeneity chi-squared = 506,06 (d.f.= 47) p = 0,000
Inconsistency (I-square) = 90,7%
No. studies = 48.
Filter OFF
Add 1/2 only zero cell studiesBMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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Table 4: Results of meta-regression analysis for predicting the presence or absence of endometrial carcinoma with variables: use or 
non-use of hormone replacement therapy (HRT); technique of ultrasound measurement (single or double layer); and population 
enrolment (consecutive or other).
Meta-Regression(Inverse Variance weights) (1)
Var. Coeff. p-value RDOR [95%CI]
Cte. 0,857 0,1571 ---- ----
S 0,263 0,0208 ---- ----
Layers 0,709 0,0610 2,03 (0,97;4,27)
Consecutive 0,206 0,7398 1,23 (0,35;4,26)
HRT 0,324 0,4152 1,38 (0,63;3,06)
Meta-Regression(Inverse Variance weights) (2)
Var. Coeff. p-value RDOR [95%CI]
Cte. 0,849 0,1565 ---- ----
S 0,253 0,0194 ---- ----
Layers 0,739 0,0424 2,09 (1,03;4,27)
HRT 0,320 0,4152 1,38 (0,63;3,02)
Meta-Regression(Inverse Variance weights) (3)
Var. Coeff. p-value RDOR [95%CI]
Cte. 0,959 0,0999 ---- ----
S 0,258 0,0166 ---- ----
Layers 0,712 0,0482 2,04 (1,01;4,13)
Table 3: Results of Spearman rank correlation of sensitivity against (1 – specificity) to assess the threshold effect in all test accuracy 
studies included in systematic review of ultrasound for prediction of endometrial cancer.
Var. Coeff. Std. Error T p-value
A 2.412 0.292 8.266 0.0000
b(1) 0.187 0.101 1.857 0.0697
Spearman correlation coefficient: 0,394 p-value = 0,006 (Logit(TPR) vs Logit(FPR)
Moses' model (D = a + bS)
Unweighted regression
Tau-squared estimate = 0,3540
(Convergence is achieved after 2 iterations)
Restricted Maximum Likelihood estimation (REML)
No. studies = 48
Filter OFFBMC Medical Research Methodology 2006, 6:31 http://www.biomedcentral.com/1471-2288/6/31
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Forrest plot Figure 7
Forrest plot. Forrest plots of Likelihood ratios for positive 
(7a) and negative (7b) test results in one homogenous sub-
group of studies of non-HRT users, with a test threshold of ≤ 
5 mm, and using a single layer technique.
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Weber 0,04    (0,01 - 0,29)
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ROC Space Figure 6
ROC Space. Representation of sensitivity against (1-specifi-
city) in Receiver Operating Characteristics space for each 
study of ultrasound in the prediction of endometrial cancer.
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sROC curve. Receiver operating characteristics curve for 
all studies included in systematic review of ultrasound for 
prediction of endometrial cancer.
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